YOLFTbeta
The Biotech Growth Trust PLC

The Biotech Growth Trust PLC

BIOG · LSE · Financial Services / Asset Management

1,400.00GBX-36.00 (-2.51%)

Price History

Full chart

Market Stats

Previous Close1,436.00
Open1,440.00
Day Range1,392.00 – 1,464.00
52-Week Range1,010.00 – 1,786.00
Volume50.43K
Market Cap278.84M
P/E (TTM)2.66
Forward P/E0.00
EPS5.58
Dividend Yield0.00%
Beta0.29
50-Day Avg1,654.00
200-Day Avg1,401.65

About

The Biotech Growth Trust PLC is a closed ended equity mutual fund launched by Frostrow Capital LLP. It is co-managed by OrbiMed Capital LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the biotechnology sector. The fund invests in stocks of companies across all market capitalizations. It employs fundamental analysis to create its portfolio. The fund benchmarks the performance of its portfolio against the NASDAQ Biotechnology Index. It was previously known as Finsbury Emerging Biotechnology Trust PLC. The Biotech Growth Trust PLC was formed on May 20, 1997 and is domiciled in the United Kingdom.

Company Details

Leadership

  • Mr. Samuel David IsalyPortfolio Manager · b. 1945

Financials

Income Statement

Currency: GBP2004-03-312005-03-312006-03-312007-03-312008-03-312009-03-312010-03-312011-03-312012-03-312013-03-312014-03-312015-03-312016-03-312017-03-312018-03-312019-03-312020-03-312021-03-312022-03-312023-03-312024-03-312025-03-312026-03-31
Total Revenue14.97M-2.15M9.68M3.14M-9.04M19.34M30.49M3.16M44.18M76.77M87.30M215.13M-126.69M100.47M-27.51M23.05M63.89M204.35M-209.71M-37.65M80.35M-77.48M137.16M
Growth (%)--114.39%+549.30%-67.56%-387.83%+314.03%+57.60%-89.63%+1297.28%+73.76%+13.71%+146.42%-158.89%+179.30%-127.38%+183.76%+177.25%+219.84%-202.62%+82.04%+313.38%-196.44%+277.01%
Cost of Revenue-------------4.03M4.35M-6.00M-5.04M-17.76M4.80M5.31M2.35M1.32M4.64M
Gross Profit14.97M-2.15M9.68M3.14M-9.04M19.34M30.49M3.16M44.18M76.77M87.30M215.13M-126.69M96.44M-31.86M29.04M68.94M222.11M-214.51M-42.97M78.00M-78.81M132.52M
Gross Margin100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%95.99%115.81%126.03%107.90%108.69%102.29%114.11%97.08%101.71%96.62%
Operating Expense942.00K899.00K1.36M2.40M-148.00K1.29M1.78M1.15M3.62M548.00K775.00K578.00K1.66M-2.41M-2.81M4.56M4.28M24.77M-14.76M-6.28M1.50M3.71M629.00K
Operating Income14.02M-3.05M8.32M737.00K-8.89M18.06M28.70M2.01M40.56M76.22M86.53M214.55M-128.35M98.86M-29.05M24.49M64.66M197.34M-199.75M-36.69M76.50M-82.52M131.89M
Operating Margin93.71%141.74%85.98%23.47%98.36%93.35%94.15%63.63%91.81%99.29%99.11%99.73%101.31%98.39%105.60%106.25%101.20%96.57%95.25%97.44%95.21%106.49%96.16%
EBITDA14.02M-3.05M8.32M737.00K-8.89M18.06M28.70M2.01M24.46M76.22M84.86M219.41M-340.00K100.83M2.39M21.29M64.66M197.34M-10.73M-5.34M75.87M-82.52M131.43M
EBITDA Margin93.71%141.74%85.98%23.47%98.36%93.35%94.15%63.63%55.36%99.29%97.20%101.99%0.27%100.36%-8.68%92.37%101.20%96.57%5.12%14.19%94.43%106.49%95.82%
Net Income14.01M-3.06M8.28M700.00K-8.93M17.98M28.69M2.00M40.52M76.15M86.34M214.26M-128.95M98.30M-29.78M21.10M60.90M200.43M-202.42M-41.30M74.60M-82.66M130.25M
Net Income Margin93.64%142.20%85.60%22.29%98.78%92.93%94.10%63.25%91.71%99.19%98.90%99.60%101.78%97.84%108.24%91.56%95.32%98.08%96.52%109.68%92.85%106.68%94.97%
Interest Expense6.00K8.00K37.00K37.00K38.00K82.00K16.00K11.00K19.00K18.00K94.00K157.00K340.00K280.00K489.00K820.00K580.00K179.00K175.00K792.00K1.11M1.32M1.14M
Interest Expense % of Total Revenue0.04%-0.37%0.38%1.18%-0.42%0.42%0.05%0.35%0.04%0.02%0.11%0.07%-0.27%0.28%-1.78%3.56%0.91%0.09%-0.08%-2.10%1.39%-1.71%0.83%

Balance Sheet

Currency: GBP2004-03-312005-03-312006-03-312007-03-312008-03-312009-03-312010-03-312011-03-312012-03-312013-03-312014-03-312015-03-312016-03-312017-03-312018-03-312019-03-312020-03-312021-03-312022-03-312023-03-312024-03-312025-03-312026-03-31
Total Assets34.08M30.74M39.07M80.53M66.47M74.48M132.92M135.20M161.87M266.66M380.43M586.53M425.14M461.50M446.07M431.23M401.19M649.53M427.45M360.51M411.42M226.63M302.25M
Total Liabilities462.00K294.00K2.51M3.73M1.97M4.28M12.51M14.38M5.74M22.22M40.19M53.23M46.58M13.08M28.68M22.36M35.62M48.06M33.24M30.22M50.11M5.42M20.32M
Total Equity33.62M30.45M36.56M76.80M64.50M70.21M120.42M120.82M156.13M239.62M340.25M533.30M378.57M447.18M417.40M408.88M365.57M601.47M394.21M330.29M361.31M221.21M281.92M
Cash289.00K301.00K729.00K-811.00K2.16M-5.69M-8.40M------01.50M1.50M2.77M2.13M8.45M0
Total Debt--1.15M1.09M-3.14M8.49M---27.88M48.38M36.19M13.08M22.12M10.84M32.74M26.78M31.74M20.17M47.08M-12.32M
Net Debt-289.00K-301.00K420.00K1.09M-811.00K978.00K8.49M-5.69M--8.40M27.88M48.38M36.19M13.08M22.12M10.84M32.74M25.28M31.74M17.40M44.95M-8.45M12.32M

Cash Flow

Currency: GBP2012-03-312013-03-312014-03-312015-03-312016-03-312017-03-312018-03-312019-03-312020-03-312021-03-312022-03-312023-03-312024-03-312025-03-312026-03-31
Operating Cash Flow-439.00K1.15M-52.25M703.00K-5.91M-5.29M-4.11M-4.40M-3.77M-5.67M-12.14M-5.89M-4.24M-5.09M-5.97M
Investing Cash Flow---9.94M43.89M58.08M-7.81M45.80M90.93M-25.55M13.03M45.69M22.34M115.85M59.54M
Financing Cash Flow-5.21M7.34M42.17M-21.21M-25.79M-29.69M25.00M-41.40M-87.17M32.73M-2.39M-37.03M-18.74M-104.29M-61.94M
Capital Expenditure00000000001.04M0000
Free Cash Flow-439.00K1.15M-52.25M703.00K-5.91M-5.29M-4.11M-4.40M-3.77M-5.67M-13.19M-5.89M-4.24M-5.09M-5.97M
Dividends Paid--------0000000
FCF to OCF100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%108.61%100.00%100.00%100.00%100.00%
Dividend Paid to FCF--------0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Earnings

Report DateJun 6, 2016Nov 7, 2016Jun 7, 2017Nov 9, 2017Jun 8, 2018Nov 9, 2018May 24, 2019Nov 12, 2019Jun 3, 2020Nov 16, 2020Jun 4, 2021Nov 11, 2021Jun 1, 2022Nov 16, 2022Nov 27, 2024Jun 4, 2025Nov 25, 2025
EPS Estimate0.000.000.000.000.000.000.000.000.000.000.000.000.000.000.00--
EPS Actual-0.511.270.430.87-1.401.47-1.14-0.471.974.530.55-1.20-3.700.910.25-3.012.73
Surprise-----------------
Timing---------------Pre-marketPre-market

Key Statistics & Ratios

Market Cap278.84M
Enterprise Value312.85M
Trailing P/E2.66
Forward P/E0.00
Price / Sales2.75
Price / Book1.06
EPS5.58
Book Value14.15
Revenue (TTM)135.02M
Gross Profit (TTM)135.02M
Profit Margin96.47%
Operating Margin97.46%
Return on Equity51.78%
Return on Assets31.17%
Shares Outstanding19.06M
Shares Float10.39M
Beta0.29
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Dividends

20011×
0.00Jul 4, 2001
19991×
0.00Aug 2, 1999
19981×
0.01Jul 13, 1998